There appears to have been a medical breakthrough at the University of Saskatchewan that could be big news for people enduring the challenges of multiple sclerosis (MS) and, perhaps, the findings may open the door to a treatment of amyotrophic lateral sclerosis (ALS).
Dr. Michael Levin is the Saskatchewan MS Research Chair. After a career in the USA, he moved to Saskatoon and Saskatchewan where the prevalence of MS is higher than average.
Now his research has identified a malfunction or injury in certain nerve cells that may trigger MS — and he has developed a medicine to combat the problem.
The researchers have identified similar challenges in nerves of those suffering from ALS. They say they can grow nerve cells in a petri dish that stop the injury triggering MS and spark regeneration of healthy ones.
In a recent TEDTalk, Dr. Levin said he believes he has cracked the MS code and the next step is to begin the multi-year journey of taking their proposed remedy through the process of clinical trials that will lead to market access to the treatment.
#USask’s Dr. Michael C. Levin (MD), SK Multiple Sclerosis Clinical Research Chair, is a #TEDxUniversityofSaskatchewan 2024 speaker
— University of Saskatchewan Research (@USaskResearch) December 14, 2023
Talk title: ‘Breakthrough discovery leads to new drugs designed to stop MS and ALS in their tracks’
Learn more at: https://t.co/3n5C8VJ03k#TEDx pic.twitter.com/TdNPE6eKUO
